.Merck beats profits requirements, raises purchases expectation on solid requirement for best medications like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Forecasts as Keytruda Sales Rise BloombergMerck Sell: Pharma Titan Posts Solid End Results, Yet Overview Tumbles Short Real estate investor's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps income and sales desires surrounded by Keytruda asset, but offers combined full-year outlook MarketWatch.